alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1
                                                                      Exhibit 15



Letter Re:  Unaudited Interim Financial Information
---------------------------------------------------

Aetna Inc.
Hartford, Connecticut

Ladies and Gentlemen:

Re: Registration Statements No. 333-07169, 333-08427, 333-08429, 333-08431,
333-52321, 333-68881, 333-52321-01, 333-52321-02, 333-52321-03, 333-52321-04,
and 333-52321-05.


With respect to the Registration Statements filed by Aetna Inc. or its
Subsidiaries, we acknowledge our awareness of the use therein of our report
dated April 26, 2000 related to our review of interim financial information.

Pursuant to Rule 436(c) under the Securities Act of 1933, such report is not
considered a part of a registration statement prepared or certified by an
accountant or a report prepared or certified by an accountant within the meaning
of Sections 7 and 11 of the Act.



                                                  /s/  KPMG LLP


Hartford, Connecticut
April 26, 2000
**Exhibit    10.4** **SECOND    AMENDMENT TO LEASE**     This Second Amendment of Lease (“Amendment”) is made    and entered into this the    10th    day of November, 2005, by and between WOODSTEAD-GROGAN OPERATING    ASSOCIATES, L.P., a New Mexico limited partnership    (“Landlord”), and CHAMPION COMMUNICATION SERVICES,    INC. (“Tenant”). WITNESSETH         WHEREAS, Landlord (as successor in interest) and Tenant are    parties to that certain Lease Agreement dated the 10th day of    November, 1994, as modified by the Modification and Ratification    of Lease Agreement dated April 4, 1995, by an additional    Modification and Ratification of Lease Agreement dated    July 24, 1995, by an additional Modification and    Ratification of Lease dated May 1, 1996, by an Extension,    Modification and Ratification of Lease dated January 1,    2000, and by a First Amendment To Lease dated December 5,    2002, all of which hereafter constitute the “Lease”,    for space described as approximately 5,702 square feet of    Net Rentable Area (the “Premises”) described as    Suites 251, 330, and 330A on the    2nd    and    3rd floors    of the building commonly known as Woodstead Court (the    “Building”) located at 1610 Woodstead Court, The    Woodlands, Texas, and being more particularly described in the    Lease; and     WHEREAS, the Term of the Lease expires on December 31, 2005    (hereinafter the “Prior Termination Date”);     WHEREAS, Tenant has requested to downsize giving back    Suites 251 and 330A retaining Suite 330 and has    furthermore requested that Term be extended for thirty six    (36) months commencing on January 1, 2006 and expiring    a 5 p.m. on December 31, 2008 and Landlord is willing    to do the same on the terms and conditions set forth below;     NOW, THEREFORE, in consideration of the mutual covenants and    agreements herein contained and other good and valuable    consideration, the receipt and sufficiency of which are hereby    acknowledged, Landlord and Tenant agree as follows:     1. Extension. The Term of the Lease is hereby    extended for thirty six (36) months (hereinafter the    “Extended Term”) commencing on January 1, 2006    (hereinafter the “Extension Date”) and expiring at    5 p.m. on December 31, 2008 (hereinafter the    “Extended Termination Date”), unless sooner terminated    in accordance with the terms of the Lease.     2. Premises. Effective on the Extension Date,    the Premises shall be reduced by Suite 251 and    Suite 330A and the Lease shall be amended to reflect the    Premises as being Suite 330 comprised of 3,221 square    feet of Net Rentable Area. See Exhibit B attached hereto    and incorporated herein.     3. Base Rent. The Base Rent, Additional Rent    and all other charges under the Lease shall be payable as    provided therein with respect to the Premises through and    including the Prior Termination Date. As of the Extension Date,    the schedule of monthly installments of Base Rent
chrs-ex102_559.htm



Exhibit 10.2

September 5, 2017

Via email

 

Coherus Biosciences, Inc.

Attn: Joan Eggert, Vice President, Transactions and Legal Affairs

Cc: Matthew R. Hooper, Senior Vice President and General Counsel

201 Redwood Shores Parkway, Suite 200

Redwood City, CA

94065

 

Re: Request for Consent to Assignment of Master Services Agreement

 

Dear Ms. Eggert,

Reference is made to the Master Services Agreement dated as of January 23, 2012 and all associated Task Orders thereunder (the "Agreement") between Medpace, Inc. ("we" or "our") and Coherus Biosciences, Inc. ("you" or "your"). Capitalized terms used but not defined herein have the meanings ascribed to them under the Agreement.

In connection with an internal reorganization of our corporate group, specifically the formation of a new entity called Medpace Research, Inc., we write to notify you that effective as of July 1, 2017 we intend to assign the Agreement, including the assignment of all of our rights under the Agreement to Medpace Research, Inc. (the "Assignee", and such assignment, the "Assignment").

Medpace Research, Inc. is a wholly owned subsidiary of Medpace, Inc.   All responsibilities of Medpace, Inc. under the Agreement will continue.  The assignment of this Agreement is consistent with internal business management allocations being made by Medpace and Medpace Research, Inc.  The Assignment will have no impact on the services provided to you under the Agreement or the contractual obligations of Medpace Inc. and Medpace Research, Inc. to you. Medpace Research, Inc. hereby assumes the obligation to perform in accordance with the terms and conditions of this Agreement.

In accordance with Section 25 of the Agreement, we hereby request your consent to the Assignment. Please sign the enclosed copy of this letter to acknowledge your consent and return it to John Wynne, Vice President, Commercial Operations, Medpace, Inc., 5375 Medpace Way, Cincinnati, Ohio 45227, using the enclosed pre-addressed and stamped envelope.  Because the Assignment is scheduled to take effect on July 1, 2017 we ask that you send us the signed consent upon receipt but in any event no later than 10 days after receipt.



If you have any questions regarding the Assignment or this request for consent, please direct them to Amy Gasser Callow, Asst. General Counsel, Medpace, Inc. at 513-579-9911 ext 12560 or a.callow@medpace.com

We appreciate your assistance and thank you in advance for your prompt attention to this matter.


	
 
	
Very truly yours,

Medpace, Inc.

	
 
	
By: /s/ John Wynne

Name: John  Wynne

Vice President, Commercial Operations

	
 
	
 

	
 
	
 

	
The undersigned hereby consents to the Assignment as of the date set forth below:

Coherus Biosciences, Inc.

By: /s/ Joan D. Eggert

Name: Joan D. Eggert

Title: VP, Transactions & Legal Affairs

Date: 06 Sep 2017




 

2
# C_2020262EN.01002301.xml

| 10.8.2020 | EN | Official Journal of the European Union | C 262/23 |
| --- | --- | --- | --- |

10.8.2020

EN

Official Journal of the European Union

C 262/23

---

Judgment of the General Court of 25 June 2020 — Serviceplan Gruppe für innovative Kommunikation v EUIPO (Serviceplan Solutions)

(Case T-380/19) (1)

(EU trade mark - Application for the EU word mark Serviceplan Solutions - Absolute ground for refusal - No distinctive character - Article 7(1)(b) of Regulation (EU) 2017/1001 - Obligation to state reasons - First sentence of Article 94(1) of Regulation 2017/1001)

(2020/C 262/30)

Language of the case: German

Parties

Applicant: Serviceplan Gruppe für innovative Kommunikation GmbH & Co. KG (Munich, Germany) (represented by: B. Koch and P. Schmitz, lawyers)

Defendant: European Union Intellectual Property Office (represented by: E. Markakis, acting as Agent)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 25 March 2019 (Case R 1427/2018-5) concerning an application for registration of the word sign Serviceplan Solutions as an EU trade mark.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Serviceplan Gruppe für innovative Kommunikation GmbH & Co. KG to pay the costs. |
| --- | --- |

2.

Orders Serviceplan Gruppe für innovative Kommunikation GmbH & Co. KG to pay the costs.

---

(1)  OJ C 270, 12.8.2019.

---
|    |                          |
|----|--------------------------|
| 1. | Purpose; Effective Date. |

|    |                 |
|----|-----------------|
| 2. | Administration. |

|    |                                     |
|----|-------------------------------------|
| 3. | Participants and Performance Goals. |

|    |                               |
|----|-------------------------------|
| 4. | Calculation of Actual Awards. |

----

|    |                           |
|----|---------------------------|
| 5. | Payment of Actual Awards. |

|    |                            |
|----|----------------------------|
| 6. | Termination of Employment. |

|    |                           |
|----|---------------------------|
| 7. | Miscellaneous Provisions. |

----
EXHIBIT 32.1     CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report of Mine Clearing Corp. (the Company) on Form 10-Q for the period ending May 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Camilo Velasquez, President, Interim Chief Executive Officer of the Company and a member of the Board of Directors, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:   (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and   (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   /s/ Camilo VelasquezCamilo VelasquezInterim Chief Executive Officer  and PresidentJuly 15, 2011
EXHIBIT 10.6

[YORK INTERNATIONAL CORPORATION LOGO]                               PERSONAL AND
                                                                    CONFIDENTIAL
                                                                    INTER-OFFICE
                                                                  CORRESPONDENCE

TO: Executive

FROM:

DATE:

RE: York International Mid-Term Plan

I am pleased to inform you that you have been approved by the Board of Directors
to participate in the (Year 1) - (Year 3) Mid-Term Incentive Plan (The "Plan")
portion of the Company's 2002 Incentive Compensation Plan. Please refer to the
2002 Incentive Compensation Plan for more details on the Plan description and
policies.

For the Plan, which is effective January 1, (Year 1) through December 31, (Year
3), your incentive compensation will be based on the following performance
goals:

      1.    Corporate Earnings Per Share (EPS) reported for (Year 3).

      2.    Corporate Return on Net Capital Employed (RONCE) for (Year 3).

There are three levels of achievement for each goal. The achievement level will
be linearly pro-rated based on actual results. The weighting for the two metrics
is 50/50.

<PAGE>

The table below shows your (Year 3) EPS and RONCE Threshold, Target and Maximum
goals as well as award percentages for goal achievement.

<TABLE>
<CAPTION>
     GOAL (WEIGHT)                      THRESHOLD          TARGET            MAXIMUM
-----------------------                 ---------          ------            -------
<S>                                     <C>                <C>               <C>
York (Year 3) EPS (50%)                     $                $                  $
  York (Year 3) RONCE
        (50%)*                              %                %                  %

   Incentive Amount                         %                %                  %
</TABLE>

*Only payable if EPS at least at Threshold

At each achievement level, bonus as a percent of salary is specified. The award
amount for each goal is determined by multiplying the bonus percentage for the
actual result by the weighting of the goal, and further by your year-end (Year
3) base annual salary rate.

Distribution of the amount earned under the Plan will be made after the
Company's results for (Year 3) have been audited. The actual timing, amounts and
individual distribution of those amounts are predicated upon actual performance,
and are ultimately approved by the Compensation Committee of the Board of
Directors. In the event of death, disability, retirement or termination, other
than for cause, payments will be prorated for the time of employment. If you
voluntarily leave the company or are terminated for cause prior to the end of
the 3-year Plan period, any incentive payment will be forfeited.

Targets are confidential information and may not be communicated outside of the
Company, and should only be discussed internally on a need-to-know basis.
<TABLE> <S> <C>


<ARTICLE>                                  7
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                                      0001013698                     
<NAME>                                     Symons International Group, Inc. 
<MULTIPLIER>                               1
<CURRENCY>                                 U.S. Dollars
       
<S>                                        <C>
<PERIOD-TYPE>                              3-mos
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<EXCHANGE-RATE>                            1
<DEBT-HELD-FOR-SALE>                       0
<DEBT-CARRYING-VALUE>                      176,370,000
<DEBT-MARKET-VALUE>                        176,370,000
<EQUITIES>                                 40,993,000
<MORTGAGE>                                 2,190,000
<REAL-ESTATE>                              3,034,000
<TOTAL-INVEST>                             232,085,000
<CASH>                                     26,295,000
<RECOVER-REINSURE>                         67,384,000
<DEFERRED-ACQUISITION>                     17,267,000
<TOTAL-ASSETS>                             678,254,000
<POLICY-LOSSES>                            126,629,000
<UNEARNED-PREMIUMS>                        205,984,000
<POLICY-OTHER>                             0
<POLICY-HOLDER-FUNDS>                      0
<NOTES-PAYABLE>                            2,569,000
<PREFERRED-MANDATORY>                      0
<PREFERRED>                                135,000,000
<COMMON>                                   38,296,000
<OTHER-SE>                                 46,351,000
<TOTAL-LIABILITY-AND-EQUITY>               678,254,000
<PREMIUMS>                                 68,485,000
<INVESTMENT-INCOME>                        2,958,000
<INVESTMENT-GAINS>                         1,968,000
<OTHER-INCOME>                             6,487,000
<BENEFITS>                                 53,205,000
<UNDERWRITING-AMORTIZATION>                511,000
<UNDERWRITING-OTHER>                       14,923,000
<INCOME-PRETAX>                            11,076,000
<INCOME-TAX>                               4,022,000
<INCOME-CONTINUING>                        7,054,000
<DISCONTINUED>                             0
<EXTRAORDINARY>                            0
<CHANGES>                                  0
<NET-INCOME>                               4,924,000
<EPS-PRIMARY>                              .47
<EPS-DILUTED>                              .46
<RESERVE-OPEN>                             136,772,000
<PROVISION-CURRENT>                        53,598,000
<PROVISION-PRIOR>                          1,397,000
<PAYMENTS-CURRENT>                         18,998,000
<PAYMENTS-PRIOR>                           31,624,000
<RESERVE-CLOSE>                            126,629,000
<CUMULATIVE-DEFICIENCY>                    0
        


</TABLE>
REGULATORY EVALUATION

Directorate Identifier: 2012-NM-098-AD

Executive Order 12866:

Could the AD be considered a “significant regulatory action”?

YES ( ) explain NO (X)

DOT Regulatory Policies and Procedures:

Is the AD significant?

YES ( ) explain NO (X)

Regulatory Flexibility Act:

Will the AD have a significant economic impact on a substantial number of small entities?

YES ( ) explain NO (X)

Intrastate Aviation in Alaska:

This AD could affect intrastate aviation in Alaska. Is it appropriate to include specific 

requirements for aircraft operated in Alaska, where aviation might be the only mode of 

transportation?

YES ( ) explain NO (X)
#### McCLENDON v. STATE.

No. 14666.

Court of Criminal Appeals of Texas.

Jan. 6, 1932.

Rehearing Denied Feb. 3, 1932.

J. D. Bell, of Paducah, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

HAWKINS, J.

Conviction is for possessing equipment for the manufacture of intoxicating liquor; punishment being one year in the penitentiary.

There appear in the transcript two notices of appeal — one dated April 20, 1931; the other dated April 29, 1931. The statement of facts was filed in the trial court more than 90 days after the last notice of appeal was entered. The statement of facts is not entitled to consideration. See subdivision 5, art. 760, C. C. P. (1925); Bailey v. State, 104 Tex. Cr. R. 150, 282 S. W. 804; Clark v. State, 105 Tex. Cr. R. 490, 288 S. W. 1075; *586Guerro v. State, 105 Tex. Cr. R. 410, 288 S. W. 1084; Courser v. State, 106 Tex. Cr. R. 146, 291 S. W. 236.

No bills of exception are brought forward in the record.

The judgment is affirmed.
---

|Exhibit 32.1                                 
|---------------------------------------------
|                                             
|CERTIFICATION PURSUANT TO                    
|18 U.S.C. SECTION 1350                       
|AS ADOPTED PURSUANT TO                       
|SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of K-Care Nutritional
Products Inc. (the "Company") on Form 10-QSB for the period ended January 31,
2007 as filed with the Securities and Exchange Commission (the "Report"), the
undersigned, in the capacities and on the dates indicated below, hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to my knowledge:

| | 1. | The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                   
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------
| |    |                                                                                                                                                                 
| | 2. | The information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.

|Dated: May 7, 2007 | /s/ Eva Dudas                                             
|------------------ | ----------------------------------------------------------
|                   | Eva Dudas                                                 
|                   | President, Chief Executive Officer,                       
|                   | Chief Financial Officer, Principal Accounting
      Office

---
*

The appellee was not served with process in the district court and is not participating

in this appeal.  After examining the appellant’s brief and the record, we have concluded that

oral argument is unnecessary.  Thus, the appeal is submitted on the brief and the record.  See

FED. R. APP. P. 34(a)(2).

United States Court of Appeals

For the Seventh Circuit

Chicago, Illinois 60604

Submitted May 1, 2009*

      Decided May 1, 2009      

Before

       RICHARD A. POSNER, Circuit Judge

       MICHAEL S. KANNE, Circuit Judge

JOHN DANIEL TINDER, Circuit Judge

No. 08‐3579

VETTER G. MOORE,

Petitioner‐Appellant,

v.

HELEN J. MARBERRY,

Respondent‐Appellee.

Appeal  from the United States District

Court for the Southern District of Indiana

Terre Haute Division.

No. 2:08‐cv‐341‐WTL‐JMS

William T. Lawrence,

Judge.

O R D E R

Vetter Moore, a federal inmate, filed a petition for habeas corpus under 28 U.S.C.

§ 2241, which the district court construed as challenging the conditions of his confinement

and his transfer from a prison in Pennsylvania to one in Indiana.  The court summarily

dismissed the petition, reasoning that Moore cannot use § 2241 to challenge the conditions

NONPRECEDENTIAL DISPOSITION

To be cited only in accordance with

 Fed. R. App. P. 32.1
No. 08‐3579 Page 2

of confinement and that transfers between federal facilities are committed wholly to the

discretion of the Federal Bureau of Prisons.

Moore appeals, but we cannot discern a legal argument in his semi‐coherent

submission.  Even pro se litigants must provide a statement of the issues presented for

review along with corresponding legal argument and citations to authorities.  See FED. R.

APP. P. 28(a)(9); Anderson v. Hardman, 241 F.3d 544, 545 (7th Cir. 2001).  As best we can tell

Moore argues that the indictment underlying his 1991 conviction was fake and that prison

officials falsely labeled him a snitch so that his cellmate would kill him.  But we fail to see

how these contentions relate to the district court’s decision and note that Moore has

repeatedly challenged the validity of his indictment in many of the 100‐plus collateral

petitions and 30 appeals he has filed in federal courts around the country.  

Accordingly, the appeal is DISMISSED.  And we caution Moore not to file anything

else covering the same ground.  We have already sanctioned him $100 and barred him from

future filings relating to Moore v. Bezy, No. 2:06‐cv‐00157‐LJM‐WTL (S.D. Ind. filed Aug. 1,

2006), and Moore v. Bezy, No. 2:06‐cv‐00017‐LJM‐WTL (S.D. Ind. filed Jan. 19, 2006).  See In re

Moore, No. 08‐1962 (7th Cir. filed May 1, 2008).  If he continues to waste this court’s time

with frivolous filings, we will impose further sanctions.